Largest health care companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 170 health care companies ranked by earnings, at R$156.8B, ahead of Eli Lilly (R$120.7B) and Merck & Co (R$106.8B). Figures as of 18 Nov 2026, 23:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- Johnson & JohnsonR$156.8B
- Median
- R$1.6B
- Combined market value
- R$53.19T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | R$156.8B | R$3.84T | R$1,594.97 | 2.15% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | R$120.7B | R$7.2T | R$8,087.43 | 2.32% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | R$106.8B | R$1.99T | R$805.85 | 3.90% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | R$88.9B | R$1.02T | R$230.62 | 3.12% down | 17% down | ||
| 5 | NovartisNVS · Health Care | R$81.8B | R$1.71T | R$907.79 | 2.46% down | 25% up | ||
| 6 | UnitedHealth GroupUNH · Health Care | R$70.5B | R$1.83T | R$2,046.55 | 10.21% down | 26% up | ||
| 7 | AstraZenecaAZN · Health Care | R$59.8B | R$1.62T | R$1,045.53 | 1.93% down | 2% up | ||
| 8 | SanofiSNY · Health Care | R$50.7B | R$661.8B | R$275.60 | 0.86% down | 4% down | ||
| 9 | Gilead SciencesGILD · Health Care | R$49.8B | R$1.23T | R$988.33 | 0.75% down | 33% up | ||
| 10 | PfizerPFE · Health Care | R$45.5B | R$935.4B | R$164.12 | 1.44% down | 14% up | ||
| 11 | AmgenAMGN · Health Care | R$45.1B | R$1.4T | R$2,596.22 | 3.07% down | 34% up | ||
| 12 | GSKGSK · Health Care | R$44.4B | R$569.5B | R$284.13 | 1.34% down | 6% up | ||
| 13 | Bristol-Myers SquibbBMY · Health Care | R$41.3B | R$712.1B | R$348.35 | 2.92% down | 34% up | ||
| 14 | HCA HealthcareHCA · Health Care | R$39.7B | R$582B | R$2,786.08 | 4.96% down | 4% up | ||
| 15 | Thermo Fisher ScientificTMO · Health Care | R$39.2B | R$1.5T | R$4,051.70 | 0.87% up | 20% up | ||
| 16 | Abbott LaboratoriesABT · Health Care | R$38.2B | R$1.06T | R$611.08 | 0.22% down | 17% down | ||
| 17 | Cigna GroupCI · Health Care | R$34.8B | R$439.8B | R$1,669.07 | 2.96% down | 8% up | ||
| 18 | Elevance HealthELV · Health Care | R$33.1B | R$506.5B | R$2,344.43 | 7.63% down | 37% up | ||
| 19 | MedtronicMDT · Health Care | R$28.1B | R$753.5B | R$589.09 | 1.56% down | 2% up | ||
| 20 | McKessonMCK · Health Care | R$27.9B | R$732.3B | R$6,342.61 | 0.66% down | 28% up | ||
| 21 | Regeneron PharmaceuticalsREGN · Health Care | R$26.3B | R$572.1B | R$5,530.22 | 1.28% down | 36% up | ||
| 22 | AbbVieABBV · Health Care | R$24.7B | R$2.96T | R$1,672.82 | 2.33% down | 26% up | ||
| 23 | Vertex PharmaceuticalsVRTX · Health Care | R$23.1B | R$795.5B | R$3,137.59 | 0.42% up | 27% up | ||
| 24 | DanaherDHR · Health Care | R$21.1B | R$940.6B | R$1,336.92 | 1.24% up | 2% up | ||
| 25 | StrykerSYK · Health Care | R$19B | R$708.4B | R$1,860.80 | 0.19% up | 13% down | ||
| 26 | Boston ScientificBSX · Health Care | R$16.9B | R$370B | R$255.24 | 1.42% up | 56% down | ||
| 27 | Intuitive SurgicalISRG · Health Care | R$16.7B | R$853.5B | R$2,462.05 | 2.23% down | 24% down | ||
| 28 | ZoetisZTS · Health Care | R$15.6B | R$203.4B | R$500.48 | 2.50% up | 29% down | ||
| 29 | Tenet HealthcareTHC · Health Care | R$13.8B | R$126.3B | R$1,587.01 | 3.80% down | 45% up | ||
| 30 | GE HealthCare TechnologiesGEHC · Health Care | R$12.2B | R$221.2B | R$489.31 | 2.22% up | 13% up | ||
| 31 | CVS HealthCVS · Health Care | R$10.3B | R$608.8B | R$475.80 | 5.20% down | 12% up | ||
| 32 | Cardinal HealthCAH · Health Care | R$10B | R$376.3B | R$1,627.84 | 0.33% down | 35% up | ||
| 33 | Becton, DickinsonBDX · Health Care | R$9.8B | R$344.2B | R$1,263.81 | 0.31% up | 43% up | ||
| 34 | SolventumSOLV · Health Care | R$9.1B | R$86B | R$505.80 | 0.49% up | 11% up | ||
| 35 | CencoraCOR · Health Care | R$9.1B | R$388.8B | R$2,037.20 | 0.64% down | 3% down | ||
| 36 | ResMedRMD · Health Care | R$8.9B | R$199.6B | R$1,418.98 | 2.00% up | 3% down | ||
| 37 | Universal Health ServicesUHS · Health Care | R$8.7B | R$62.7B | R$1,088.29 | 3.08% down | 16% down | ||
| 38 | Teva Pharmaceutical IndustriesTEVA · Health Care | R$8.2B | R$288.2B | R$246.99 | 0.92% down | 74% up | ||
| 39 | IQVIA HoldingsIQV · Health Care | R$8B | R$248.5B | R$1,508.05 | 0.09% up | 18% up | ||
| 40 | United TherapeuticsUTHR · Health Care | R$7.8B | R$143.8B | R$3,376.75 | 1.16% down | 23% up | ||
| 41 | Agilent TechnologiesA · Health Care | R$7.6B | R$292.4B | R$1,037.17 | 2.97% up | 19% up | ||
| 42 | BiogenBIIB · Health Care | R$7.6B | R$217.4B | R$1,470.45 | 0.25% up | 49% up | ||
| 43 | argenxARGX · Health Care | R$7.6B | R$346.2B | R$5,505.18 | 0.66% down | 4% up | ||
| 44 | IncyteINCY · Health Care | R$7.5B | R$140.4B | R$688.99 | 1.08% down | 18% up | ||
| 45 | HumanaHUM · Health Care | R$6.9B | R$271B | R$2,256.35 | 12.98% down | 94% up | ||
| 46 | MedlineMDLN · Health Care | R$6.8B | R$301.4B | R$229.04 | 3.93% up | 8% down | ||
| 47 | Fresenius Medical CareFMS · Health Care | R$6.3B | R$63.6B | R$122.53 | 3.41% down | 5% down | ||
| 48 | Edwards LifesciencesEW · Health Care | R$6.3B | R$353.9B | R$615.47 | 0.19% down | 23% up | ||
| 49 | IDEXX LaboratoriesIDXX · Health Care | R$6.2B | R$321.9B | R$4,085.21 | 1.19% up | 1% down | ||
| 50 | Koninklijke PhilipsPHG · Health Care | R$5.8B | R$170.4B | R$174.35 | 0.27% down | 10% up | ||
| 51 | Quest DiagnosticsDGX · Health Care | R$5.8B | R$167.1B | R$1,518.87 | 1.30% up | 38% up | ||
| 52 | AlconALC · Health Care | R$5.7B | R$211.5B | R$440.18 | 1.55% up | 2% down | ||
| 53 | GenmabGMAB · Health Care | R$5.6B | R$183.8B | R$298.11 | 1.91% down | 70% up | ||
| 54 | Labcorp HoldingsLH · Health Care | R$5.1B | R$176.1B | R$2,168.62 | 0.69% up | 41% up | ||
| 55 | Mettler-Toledo InternationalMTD · Health Care | R$5.1B | R$202.1B | R$10,160.89 | 1.42% up | 22% up | ||
| 56 | IlluminaILMN · Health Care | R$5B | R$185.7B | R$1,228.31 | 3.65% up | 69% up | ||
| 57 | DexComDXCM · Health Care | R$4.9B | R$180B | R$482.64 | 0.59% up | 37% up | ||
| 58 | ExelixisEXEL · Health Care | R$4.6B | R$97.5B | R$399.41 | 0.31% down | 63% up | ||
| 59 | STERISSTE · Health Care | R$4.6B | R$147.4B | R$1,518.17 | 0.84% up | 1% up | ||
| 60 | Royalty PharmaRPRX · Health Care | R$4.5B | R$230.9B | R$401.64 | 0.01% down | 78% up | ||
| 61 | Bio-Rad LaboratoriesBIO · Health Care | R$4.4B | R$58.2B | R$2,165.05 | 3.34% up | 18% up | ||
| 62 | DaVitaDVA · Health Care | R$4.4B | R$59.5B | R$946.28 | 6.48% down | 50% up | ||
| 63 | Zimmer Biomet HoldingsZBH · Health Care | R$4.1B | R$114.4B | R$604.30 | 1.20% up | 14% up | ||
| 64 | PTC TherapeuticsPTCT · Health Care | R$4B | R$29.4B | R$352.27 | 0.22% down | 20% down | ||
| 65 | WatersWAT · Health Care | R$3.8B | R$535.8B | R$2,726.13 | 3.63% up | 20% up | ||
| 66 | Smith & NephewSNN · Health Care | R$3.7B | R$74.1B | R$177.34 | 0.62% down | 5% down | ||
| 67 | Encompass HealthEHC · Health Care | R$3.3B | R$77.4B | R$789.18 | 2.14% down | 23% up | ||
| 68 | Globus MedicalGMED · Health Care | R$3.1B | R$54.6B | R$412.52 | 0.77% up | 16% down | ||
| 69 | West Pharmaceutical ServicesWST · Health Care | R$2.9B | R$164.6B | R$2,363.03 | 2.44% down | 61% up | ||
| 70 | Neurocrine BiosciencesNBIX · Health Care | R$2.8B | R$96.4B | R$952.54 | 1.84% down | 20% up | ||
| 71 | Molina HealthcareMOH · Health Care | R$2.8B | R$63.1B | R$1,208.13 | 6.62% down | 60% up | ||
| 72 | Dr. Reddy's LaboratoriesRDY · Health Care | R$2.7B | R$73B | R$87.62 | 1.28% up | 5% up | ||
| 73 | Medpace HoldingsMEDP · Health Care | R$2.6B | R$105.8B | R$3,783.41 | 0.95% down | 10% up | ||
| 74 | TG TherapeuticsTGTX · Health Care | R$2.6B | R$58.5B | R$386.72 | 5.44% up | 107% up | ||
| 75 | GrifolsGRFS · Health Care | R$2.6B | R$33.7B | R$49.54 | 1.85% down | 1% up | ||
| 76 | QiagenQGEN · Health Care | R$2.5B | R$59.9B | R$289.87 | 0.38% down | 12% up | ||
| 77 | Align TechnologyALGN · Health Care | R$2.4B | R$67.6B | R$958.97 | 0.31% up | 22% up | ||
| 78 | Henry ScheinHSIC · Health Care | R$2.3B | R$55.4B | R$501.18 | 3.32% up | 17% up | ||
| 79 | Cooper CompaniesCOO · Health Care | R$2.2B | R$67.6B | R$355.31 | 0.05% up | 16% down | ||
| 80 | BioMarin PharmaceuticalBMRN · Health Care | R$2B | R$69.6B | R$359.29 | 4.99% up | 11% up | ||
| 81 | Ensign GroupENSG · Health Care | R$2B | R$62.4B | R$1,070.21 | 1.63% down | 4% up | ||
| 82 | Halozyme TherapeuticsHALO · Health Care | R$1.9B | R$63.9B | R$560.32 | 0.18% down | 37% up | ||
| 83 | Alnylam PharmaceuticalsALNY · Health Care | R$1.8B | R$117B | R$873.81 | 4.54% down | 66% down | ||
| 84 | BeOne MedicinesONC · Health Care | R$1.7B | R$269.6B | R$2,360.58 | 2.34% down | 17% up | ||
| 85 | MSA SafetyMSA · Health Care | R$1.6B | R$40B | R$1,037.87 | 2.67% up | 11% up | ||
| 86 | ChemedCHE · Health Care | R$1.6B | R$41.4B | R$3,197.66 | 0.01% down | 27% up | ||
| 87 | InsuletPODD · Health Care | R$1.4B | R$56.8B | R$818.72 | 3.69% down | 58% down | ||
| 88 | AlkermesALKS · Health Care | R$1.4B | R$46B | R$274.02 | 3.08% up | 58% up | ||
| 89 | RevvityRVTY · Health Care | R$1.4B | R$99.5B | R$891.53 | 3.14% up | 60% up | ||
| 90 | Lantheus HoldingsLNTH · Health Care | R$1.4B | R$39B | R$596.58 | 0.20% up | 93% up | ||
| 91 | ICONICLR · Health Care | R$1.3B | R$85.5B | R$1,141.45 | 0.07% up | 23% up | ||
| 92 | HealthEquityHQY · Health Care | R$1.3B | R$47.1B | R$569.15 | 4.45% down | 2% down | ||
| 93 | Option Care HealthOPCH · Health Care | R$1.2B | R$27.8B | R$185.47 | 0.25% up | 14% up | ||
| 94 | Krystal BiotechKRYS · Health Care | R$1.2B | R$54.7B | R$1,844.36 | 5.62% up | 46% up | ||
| 95 | PACS GroupPACS · Health Care | R$1.1B | R$43B | R$270.80 | 4.63% down | 188% up | ||
| 96 | BrightSpring Health ServicesBTSG · Health Care | R$1.1B | R$79.5B | R$399.71 | 2.13% down | 116% up | ||
| 97 | Bio-TechneTECH · Health Care | R$1.1B | R$66.8B | R$425.50 | 0.17% up | 26% up | ||
| 98 | PenumbraPEN · Health Care | R$1B | R$73.9B | R$1,875.13 | 0.47% up | 13% up | ||
| 99 | Concentra Group Holdings ParentCON · Health Care | R$973.3M | R$30.9B | R$245.53 | 0.94% down | 120% up | ||
| 100 | Merit Medical SystemsMMSI · Health Care | R$751.5M | R$30.1B | R$502.59 | 1.70% up | 1% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 5.8488 BRL).
Questions and answers
Which health care companies rank first by earnings?
Johnson & Johnson (R$156.8B), Eli Lilly (R$120.7B) and Merck & Co (R$106.8B) are the top three of the 170 health care companies ranked by earnings as of 18 Nov 2026, 23:16 UTC.
How many health care companies are in this ranking?
170 are ranked by earnings.
What are these health care companies worth together?
The 170 health care companies ranked by earnings have a combined market value of R$53.19T as of 18 Nov 2026, 23:16 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/sector/health-care?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.